Life Science Tools, MDx M&A Deals Rise 15 Percent in H1 2011 | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the life science 'omics tools and molecular diagnostics space rose 15 percent year over year for the first half of 2011, spurred on by the low cost of debt and a handful of companies that proved to be especially aggressive buyers.

Despite the uptick, though, the M&A environment remains mixed and the forecast for the near future is unclear, according to industry observers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

Sponsored by
Agilent Technologies

In this online seminar, speakers from the Center for Personalized Diagnostics at Penn Medicine will discuss the design and technical validation of a custom next-generation sequencing panel to detect mutations in a wide array of tumor types.